WallStreetZenWallStreetZen

NASDAQ: PCVX
Vaxcyte Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for PCVX

Based on 3 analysts offering 12 month price targets for Vaxcyte Inc.
Min Forecast
$80.00+33.2%
Avg Forecast
$96.00+59.84%
Max Forecast
$113.00+88.15%

Should I buy or sell PCVX stock?

Based on 3 analysts offering ratings for Vaxcyte Inc.
Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their PCVX stock forecasts and price targets.

PCVX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-10
lockedlocked$00.00+00.00%2024-03-12Find Out Why
lockedlocked$00.00+00.00%2024-01-02Find Out Why

1 of 1

Forecast return on equity

Is PCVX forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.16%

Forecast return on assets

Is PCVX forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

PCVX revenue forecast

What is PCVX's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$150.0M
Avg 2 year Forecast
$47.0M
Avg 3 year Forecast
$82.3M

PCVX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
PCVX$60.06$96.00+59.84%Strong Buy
CYTK$64.80$87.36+34.82%Strong Buy
JAZZ$107.43$193.09+79.74%Strong Buy
IONS$41.84$56.78+35.70%Buy
EXEL$23.53$27.17+15.46%Buy
View Top Biotech Stocks

Vaxcyte Stock Forecast FAQ

Is Vaxcyte Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: PCVX) stock is to Strong Buy PCVX stock.

Out of 3 analysts, 2 (66.67%) are recommending PCVX as a Strong Buy, 1 (33.33%) are recommending PCVX as a Buy, 0 (0%) are recommending PCVX as a Hold, 0 (0%) are recommending PCVX as a Sell, and 0 (0%) are recommending PCVX as a Strong Sell.

If you're new to stock investing, here's how to buy Vaxcyte stock.

What is PCVX's revenue growth forecast for 2026-2028?

(NASDAQ: PCVX) Vaxcyte's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.04%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.92%.

Vaxcyte's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast PCVX's revenue for 2026 to be $16,261,159,500, with the lowest PCVX revenue forecast at $16,261,159,500, and the highest PCVX revenue forecast at $16,261,159,500. On average, 2 Wall Street analysts forecast PCVX's revenue for 2027 to be $5,095,163,310, with the lowest PCVX revenue forecast at $1,550,230,539, and the highest PCVX revenue forecast at $8,640,096,081.

In 2028, PCVX is forecast to generate $8,916,535,793 in revenue, with the lowest revenue forecast at $1,550,230,539 and the highest revenue forecast at $16,282,841,046.

What is PCVX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: PCVX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is PCVX's Price Target?

According to 3 Wall Street analysts that have issued a 1 year PCVX price target, the average PCVX price target is $96.00, with the highest PCVX stock price forecast at $113.00 and the lowest PCVX stock price forecast at $80.00.

On average, Wall Street analysts predict that Vaxcyte's share price could reach $96.00 by Apr 10, 2025. The average Vaxcyte stock price prediction forecasts a potential upside of 59.84% from the current PCVX share price of $60.06.

What is PCVX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: PCVX) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.